AI could revolutionize liver cancer care by predicting who needs extra treatment after surgery

NCT ID NCT07417800

First seen Feb 23, 2026 · Last updated Jun 18, 2026 · Updated 13 times

Summary

This study is building an artificial intelligence (AI) model to help doctors decide which liver cancer patients should receive additional treatments like chemotherapy or targeted drugs after surgery. Researchers will analyze medical images and tissue samples from 11,000 patients to train the AI. The goal is to personalize treatment, reduce side effects, and lower the high chance of cancer returning.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • the Second Affiliated Hospital Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, Zhejiang, 310009, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.